We found that reduction of TIM23–NOX4 interaction abrogates mitochondrial ROS and metabolic reprogramming, suggesting that TIM23–NOX4 interaction may become an important therapeutic target for the treatment of lung fibrosis. This evidence concerns the gene NOX4 and pulmonary fibrosis.